Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01898208 · ClinicalTrials.gov registry record · NA
Rapid Identification and Susceptibility Testing of Pathogens From Blood Cultures
A NA study, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 743
- Enrollment target
NCT01898208: Completed NA study, sponsored by Mayo Clinic.
NCT01898208 is a NA study that has completed, run by Mayo Clinic. The registered enrollment target is 743 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01898208, a NA study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 743 participants
- Enrollment target
Study Summary
Would rapid identification of bacteria and rapid detection of methicillin-resistant S. aureus (MRSA) and vancomycin-resistant enterococci (VRE) (using an FDA-cleared assay) in positive blood culture bottles improve patient care at Mayo Clinic Rochester (or just lead to increased cost)?
Interventions
- DEVICE FilmArray testing
- BEHAVIORAL Antimicrobial Stewardship
- OTHER Bacterial culture
- OTHER Susceptibility testing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 743 participants |
| Start Date | 2013-08 |
| Est. Completion | 2014-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01898208
The ClinicalTrials.gov registry entry for NCT01898208 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 743 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which FilmArray testing is the first listed.
NCT01898208 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01898208 about?
NCT01898208 is a clinical study titled "Rapid Identification and Susceptibility Testing of Pathogens From Blood Cultures". Would rapid identification of bacteria and rapid detection of methicillin-resistant S. aureus (MRSA) and vancomycin-resistant enterococci (VRE) (using an FDA-cleared assay) in positive blood culture bottles improve patient care at Mayo Clinic Rochester (or just lead to increased cost)?
What is the current status of trial NCT01898208?
This trial is currently completed. It is a NA study. The enrollment target is 743 participants. The study started on 2013-08. Estimated completion is 2014-08.
What interventions are being tested in trial NCT01898208?
The interventions under investigation include: FilmArray testing (DEVICE), Antimicrobial Stewardship (BEHAVIORAL), Bacterial culture (OTHER), Susceptibility testing (OTHER).
Who is sponsoring clinical trial NCT01898208?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.